{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T17:41:11Z","timestamp":1715967671655},"reference-count":28,"publisher":"Japan Atherosclerosis Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT"],"published-print":{"date-parts":[[2009]]},"DOI":"10.5551\/jat.no526","type":"journal-article","created":{"date-parts":[[2011,6,16]],"date-time":"2011-06-16T13:45:38Z","timestamp":1308231938000},"page":"509-516","source":"Crossref","is-referenced-by-count":4,"title":["Effects of Rosuvastatin on Low-Density Lipoprotein Cholesterol and Plasma Lipids in Asian Patients with Hypercholesterolemia"],"prefix":"10.5551","volume":"16","author":[{"given":"Arthur TH","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lip-Ping","family":"Low","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin Hock","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chee Eng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.278.4.313"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67394-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Pearson TA, Laurora I, Chu H, Kafonek S: The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med, 2000; 160: 459-467","DOI":"10.1001\/archinte.160.4.459"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04235-5"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2001.2610"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.11.015"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000133317.49796.0E"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Pedersen TR, Berg K, Cook TJ, Faergeman O, Haghfelt T, Kjekshus J, Miettinen T, Musliner TA, Olsson AG, Pyorala K, Thorgeirsson G, Tobert JA, Wedel H, Wilhelmsen L: Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. Arch Intern Med, 1996; 156: 2085-2092","DOI":"10.1001\/archinte.1996.00440170097011"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2002.129312"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.06.013"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2006.03.003"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Tzeng T, Mitchell P, Zhang H, Kung L, Schneck D, Birmingham B: Population pharmacokinetics of rosuvastatin in normal subjects and subjects with dyslipidaemia. Clin Pharmacol Ther, 2004; 75: P56 [Abstract]","DOI":"10.1016\/j.clpt.2003.11.214"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) National Cholesterol Education Program Adult Treatment Panel III: Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 2002; 106: 3143-3421","DOI":"10.1161\/circ.106.25.3143"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1592\/phco.26.4.469"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2004.11.015"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1097\/00043798-200112000-00008"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00003-1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto JW, for the STELLAR Study Group: Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial). Am J Cardiol, 2003; 92: 152-160","DOI":"10.1016\/S0002-9149(03)00530-7"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.5551\/jat.10.329"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Berne C, Siewert-Delle A, for the URANUS study investigators: Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study. Cardiovasc Diabetol, 2005; 4:7 doi:10.1186\/1475-2840-4-7","DOI":"10.1186\/1475-2840-4-7"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2004.00450.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Schneck DW, Knopp RH, Ballantyne CM, McPherson R, Chitra RR, Simonson SG: Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease. Am J Cardiol, 2003; 91: 33-41","DOI":"10.1016\/S0002-9149(02)02994-6"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00004-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) McTaggart F: Comparative pharmacology of rosuvastatin. Atheroscler Suppl, 2003; 4: 9-14","DOI":"10.1016\/S1567-5688(03)00004-7"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Chapman MJ, McTaggart F: Optimizing the pharmacology of statins: characteristics of rosuvastatin. Atheroscler Suppl, 2002; 2: 33-37","DOI":"10.1016\/S1567-5688(01)00016-2"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Hamelin BA, Turgeon J: Hydrophilicity\/lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors. Trends Pharmacol Sci, 1998; 19: 26-37","DOI":"10.1016\/S0165-6147(97)01147-4"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X242809"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.01.028"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T18:46:49Z","timestamp":1621536409000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jat\/16\/4\/16_No526\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.no526","relation":{},"ISSN":["1880-3873","1340-3478"],"issn-type":[{"value":"1880-3873","type":"electronic"},{"value":"1340-3478","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}